[1]朱同华,杨鸿林,钮丽萍.血浆CYFRA21-1和CA125、CA199、CA153联合检测对肺癌的辅助诊断价值[J].国际放射医学核医学杂志,2014,38(5):304-308.[doi:10.3760/cma.j.issn.1673-4114.2014.05.007]
　Zhu Tong-hua,Yang Hong-lin,Niu Li-ping.The value of combined detection of plasma CYFRA21-1 and CA125, CA199, CA153 in the accessory diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):304-308.[doi:10.3760/cma.j.issn.1673-4114.2014.05.007]
点击复制

血浆CYFRA21-1和CA125、CA199、CA153联合检测对肺癌的辅助诊断价值(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
38
期数:
2014年第5期
页码:
304-308
栏目:
出版日期:
2014-09-25

文章信息/Info

Title:
The value of combined detection of plasma CYFRA21-1 and CA125, CA199, CA153 in the accessory diagnosis of lung cancer
作者:
朱同华;  杨鸿林;  钮丽萍
吴江区第一人民医院检验科, 苏州, 215200
Author(s):
Zhu Tong-hua;  Yang Hong-lin;  Niu Li-ping
Department of Clinical Laboratory, the First People’s Hospital of Wujiang, Suzhou 215200, China
关键词:
肺肿瘤; 角蛋白; CA-125抗原; CA-199抗原; CA-153抗原; 放射免疫测定; 化学发光测定法
Keywords:
Lung neoplasms; Keratin; CA-125 antigen; CA-199 antigen; CA-153 antigen; Radioimmunoassay; Chemiluminescent measurements
DOI:
10.3760/cma.j.issn.1673-4114.2014.05.007
摘要:
目的 探讨血浆细胞角蛋白19片段(CYFRA21-1)和糖链抗原肿瘤标志物水平测定对肺癌诊断的临床意义。方法 采用放射免疫分析法和化学发光免疫法检测了184例肺癌患者(包括81例肺鳞癌、68例肺腺癌和35例小细胞肺癌患者)的血浆CYFRA21-1和糖链抗原125、199和153(CA125、CA199和CA153)水平,并与51例肺部良性疾病患者和60名正常对照者进行了比较性分析;进行了肿癌标志物诊断肺癌的不同联合测定情况下的灵敏度、特异度和准确率的比较。结果 与51例肺部良性疾病患者相比,184例肺癌患者的血浆CYFRA21-1、CA125、CA199和CA153水平显著升高(tCYFRA21-1=5.637, P<0.001;tCA125=3.106, P<0.01;tCA199=4.456, P<0.001;tCA153=3.763, P<0.01)。与60名正常对照者相比,184例肺癌患者的血浆CYFRA21-1、CA125、CA199和CA153水平显著升高(tCYFRA21-1=8.612,tCA125=4.067,tCA199=4.872, tCA153=8.673,P均<0.001)。与60名正常对照者相比,51例肺部良性疾病患者的血浆CYFRA21-1水平显著升高(tCYFRA21-1=6.327,P<0.001);CA125和CA153水平升高(tCA125=2.264,tCA153=2.343,P均<0.05);CA199水平差异无统计学意义(tCA199=1.761,P>0.05)。在184例肺癌中,81例肺鳞癌患者的血浆CYFRA21-1水平升高最为显著,68例肺腺癌患者的血浆CA125、CA199和CA153水平升高最为明显。单项肿瘤标志物检测CYFRA21-1的灵敏度(59.78%)和准确率(70.17%)最好,CA199的特异度(28.83%)最高。而四项联合检测肺癌的灵敏度(93.48%)和准确率(86.44%)为最高,明显高于单项和两项的检测。结论 血浆CYFRA21-1、CA125、CA199和CA153水平测定是诊断肺癌的有价值肿瘤标志物,它们的联合测定可以提高诊断灵敏度和准确率。
Abstract:
Objective To explore the clinical significance of combined detection of plasma (cytokerantin-19-fragment, CYFRA21-1)and carbohydrate antigen tumor markers levels for lung cancer diagnosis. Methods The plasma CYFRA21-1 and carbohydrate antigen (CA125, CA199 and CA153)levels were measured with radio immunoassay and chemiluminescent immunoassay in 184 patients with lung cancer (including 81 cases of lung squanous carcinoma, 68 cases of adeno-carcinoma, 35 cases of small cell lung cancer), and then compared with 51 patients with benign lung disease and 60 healthy controls. The sensitivities, specificities and accuracies of different combination of those markers for the diagnosis of lung cancer were compared. Results The plasma CYFRA21-1 and carbohydrate antigen (CA125, CA199 and CA153)levels in 184 patients with lung cancer were significantly higher than those in 51 patients with benign lung disease (tCYFRA21-1=5.637, P<0.001;tCA125=3.106, P<0.01;tCA199=4.456, P<0.001;tCA153=3.763, P<0.01)and 60 healthy controls (tCYFRA21-1=8.612, tCA125=4.067, tCA199=4.872, tCA153=8.673, all P<0.001). Compared with the 60 healthy controls, plasma levels of CYFRA21-1 in 51 cases with benign lung disease were significantly higher (tCYFRA21-1=6.327, P<0.001);CA125 and CA153 levels were increased (tCA125=2.264, tCA153=2.343, P<0.05);and there are no significant difference in CA199 levels (tCA199=1.761, P>0.05). In 184 lung cancer patients, the plasma CYFRA21-1 levels in 81 patients with lung squanous-carcinoma was the highest, but the plasma CA125, CA199, and CA153 levels in 68 patients with lung sdeno-careinoma were the highest. The CYFRA21-1 had the highest sensitivity (59. 78%)and accuracy (70.17%)and CA199 had the highest specificity (28.83%)for detecting lung cancer. The combined detection of the four items has the highest sensitivity and accuracy (93.48%and 86.44%)in the diagnosis of lung cancer, obviously higher than single or two items combined detection. Conclusions The plasma CYFRA21-1, CA125, CA199 and CA153 were valuable tumor markers for the diagnosis of lung cancer. The combination of the tumor markers could improve the diagnostic sensitivity and accuracy.

参考文献/References:

[1] 白孝雪,张研蓓.肺癌肿瘤标志物检测的研究现状[J].临床肺科杂志,2011,16(2):259-260.
[2] 刘红,李海燕,王静,等.肿瘤标志物联合胸部影像学在肺癌早期诊断中的价值[J].实用医学杂志,2012,28(12):2078-2080.
[3] Kasprzak A,Zabel M,Biczysko W.Selected markers(Chromogranin A,neuron-specific enolase,Synaptophysin,proteingene product 9.5) in diagnosis of neuroendocrine pulmonary tumours[J].Pol J pathol,2007,58(1):23-33.
[4] Ekman S,Eriksson P,Bergstron S,et al.Clinical value of using serological cytokeratins of therspcific markers in thoracic malignancie[J].Anticancer Res,2007,27(58):3545-3553.
[5] Monteiro E,Varzim G,Crespo M,et al.Varzim GME,CYFRA21-1,TPS and SCC in Squamous cell carcinoma larynx[J].An Otorrinlaringol Ibero Am,2003,30(5):4674-4679.
[6] Haizakis KD,Froudarakis ME,Bouros D,et al.Prognosic value of serum tumor markers in patients with lung cancer[J].Respiration,2002,69(1):26-37.
[7] Shitrit D,Zingerman B,Shitrit AB,et al.Diagnostic Value of CYFRA21-1,CEA,CA19-9,CA15-3,CA125 assay in pleural effusion:analysis of 116 cases and review of the litersture[J].Oncologist,2005,10(2):501-507.
[8] 郝青林,孙士波,谭波,等.糖类抗原联合检测对肺癌合并胸腔积液的诊断价值[J].国际呼吸杂志,2008,28(18):1094-1096.
[9] Schiller JH,Harring TD,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small cell lung cancer[J].N Engl J Med,2002,346(2):92-98.
[10] Ustiln H,Borazan A,Bilgicli N,et al.Diagnostic value of tumoural markers in pleural effusions[J].Int J Clin Pract,2004,58:22-25.
[11] Takahide K,Hiroaki S,Hiroichi I,et al.Serum of CA19-9 in patients with nonmalignant respiratory disease[J].J Clin Lab Anal,2007,21(2):103-106.
[12] 陈铎,李为民,王冬梅,等.联合检测血清肿瘤标志物在肺癌诊断中的价值[J].四川大学学报:医学版,2008,39(5):832-835.
[13] Li CS,Cheng BC,Ge W,et al.Clinical value of CYFRA21-1,NSE,CA153,CA199,CA125 assay in the elderly patients with pleural effusions.Int J Clin Pract[J].2007,61(3):444-448.

相似文献/References:

[1]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
　Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[2]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
　Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[3]张艳兰,孙琦婷,武萍,等.呼吸门控PET/CT对于肺癌放疗靶区勾画的指导[J].国际放射医学核医学杂志,2015,39(2):105.[doi:10.3760/cma.j.issn.1673-4114.2015.02.001]
　Zhang Yanlan,Sun Qiting,Wu Ping,et al.Guiding the target delineation in radiation therapy of lung cancer by respiratory gated PET/CT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):105.[doi:10.3760/cma.j.issn.1673-4114.2015.02.001]
[4]张高潮,马丽,寇莹,等.99Tcm-tetrofosmin SPECT诊断肺部肿瘤的临床价值[J].国际放射医学核医学杂志,2015,39(4):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
　Zhang Gaochao,Ma Li,Kou Ying,et al.Clinical value of 99Tcm-tetrofosmin SPECT in the diagnosis of lung neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):303.[doi:10.3760/cma.j.issn.1673-4114.2015.04.007]
[5]付畅,史大鹏,徐俊玲,等.不同组织学类型肺癌患者大脑静息葡萄糖代谢改变研究[J].国际放射医学核医学杂志,2014,38(2):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
　Fu Chang,Shi Dapeng,Xu Junling,et al.The preliminary study of brain glucose metabolism changes in patients with lung cancer of different histological types[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):75.[doi:10.3760/cma.j.issn.1673-4114.2014.02.002]
[6]张俊涛.晚期肺癌125I粒子植入治疗近期疗效观察[J].国际放射医学核医学杂志,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
　Zhang Juntao.Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
[7]杨心蕊,卫华,郝新忠,等.过敏性肺炎伴左肺动脉栓塞18F-FDGPET/CT误诊肺癌一例[J].国际放射医学核医学杂志,2014,38(2):135.[doi:10.3760/cma.j.issn.1673-4114.2014.02.014]
[8]王芹,杜利清,徐畅,等.白细胞介素21基因联合放射对肺癌细胞生长的协同抑制作用[J].国际放射医学核医学杂志,2014,38(3):161.[doi:10.3760/cma.j.issn.1673-4114.2014.02.005]
　Wang Qin,Du Liqing,Xu Chang,et al.Synergism inhibition effect of adenovirus-mediated IL-21 gene combined with ionizing radiation on the growth of pulmonary carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):161.[doi:10.3760/cma.j.issn.1673-4114.2014.02.005]
[9]廖江荣,蒲德利,程毅力,等.经纤支镜和经皮联合植入125I粒子治疗晚期肺癌气管狭窄的临床分析[J].国际放射医学核医学杂志,2013,37(3):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
　LIAO Jiang-rong,PU De-li,CHENG Yi-li,et al.The clinical analysis of 125I particles implantation by fibrobronchoscope and percutaneous in the treatment of tracheal stenosis of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
[10]胡丽丽,李小东,张雪宁,等.影像引导下125I粒子植入治疗肺癌的疗效分析[J].国际放射医学核医学杂志,2013,37(4):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
　HU Li-li,LI Xiao-dong,ZHANG Xue-ning,et al.Efficacy of CT guided radioactive 125I seed implantation in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]

备注/Memo

备注/Memo:
收稿日期:2013-09-29。
通讯作者:朱同华(Email:752679611@qq.com)
更新日期/Last Update: 1900-01-01